Document is current
Any future updates will be listed below
-
Authors
Scorsetti, Marta
Navarria, Pierina
Cozzi, Luca
Clerici, Elena
Bellu, Luisa
Franceschini, Davide
Marzo, Antonio Marco
Franzese, Ciro
Torri, Valter
Reggiori, Giacomo
Lobefalo, Francesca
Raspagliesi, Luca
Attuati, Luca
Pessina, Federico
Franzini, Andrea
Picozzi, Piero
Tomatis, Stefano
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct02355613 at ClinicalTrials.govDocuments that mention this clinical trial
Radiosurgery of limited brain metastases from primary solid tumor: results of the randomized phase III trial (NCT02355613) comparing treatments executed with a specialized or a C-arm linac-based platform
https://doi.org/10.1186/s13014-023-02216-5
-
Funding
Funding for this research was provided by:
Varian Medical Systems
- License Information
-
More Information
Article History
Received: 16 November 2022
Accepted: 30 January 2023
First Online: 7 February 2023
Declarations
:
: The present is a single institute prospective randomized, double-arms phase 3 trial approved by our institutional review board, registered at the ClinicalTrials.gov site with the number NCT02355613. The trial was approved by the Institutional Review Board, and it was monitored by the institutional Data and Safety Monitoring Board. All patients provided written informed consent to the treatment and the use of their data for scientific purposes.
: Post my preprint.
: L.C. acts as Scientific Advisor to Varian Medical Systems and is Clinical Research Scientist at Humanitas Cancer Center. The other authors declare no competing interests.
